Pediatric Antibiotic Use Associated With Respiratory Syncytial Virus and Influenza in the United States, 2008–2018 - Takeaways - MDSpire

Pediatric Antibiotic Use Associated With Respiratory Syncytial Virus and Influenza in the United States, 2008–2018

  • By

  • Laura M King

  • Katia J Bruxvoort

  • Sara Y Tartof

  • Joseph A Lewnard

  • June 7, 2025

  • 0 min

Share

  • 1

    6.3% of pediatric antibiotic prescriptions were associated with respiratory syncytial virus (RSV) and 3.4% with influenza from 2008 to 2018.

  • 2

    The highest incidence of RSV-associated antibiotic prescriptions occurred in children aged 5 years or younger, while influenza-associated prescriptions peaked in older children.

  • 3

    Macrolides were the antibiotic class most influenced by RSV and influenza, indicating a significant impact on prescribing practices.

  • 4

    Preventive measures, including immunization against RSV and influenza, may help reduce antibiotic use and combat antibiotic resistance in children.

  • 5

    The study utilized time series models to analyze antibiotic prescription rates in relation to RSV and influenza circulation patterns.

Original Source(s)

Pediatric Antibiotic Use Associated With Respiratory Syncytial Virus and Influenza in the United States, 2008–2018

  • by Laura M King, Katia J Bruxvoort, Sara Y Tartof, Joseph A Lewnard

  • June 7, 2025

Related Content

Rare Ebola Strain Sparks Global Alert

CDC urges travelers returning from Central Africa to monitor for Ebola symptoms for 21 days.

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Case Report: BKV-specific T cells: a fast, safe and potentially effective treatment option for refractory BKV infections in pediatric patients after allogeneic stem cell transplantation